Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2: genes and variants
Explore variant evidence for Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 across 3 analyzed proteins (NCF2, NCF1, NCF4). Linked ClinVar records include 9 pathogenic or likely pathogenic variants, 224 variants of uncertain significance and 16 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2
NCF2: Neutrophil cytosol factor 2
It helps activate the phagocyte NADPH oxidase by assembling with membrane and cytosolic partners during the respiratory burst. Biallelic loss-of-function variants cause chronic granulomatous disease and impaired killing of catalase-positive bacteria and fungi.
6 ClinVar pathogenic / likely pathogenic and 139 uncertain variants in NCF2 have source records linked to Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2. Association strength is not clinical gene validity.
NCF1: Neutrophil cytosol factor 1
After phagocyte activation, it joins the NADPH oxidase complex to generate microbicidal reactive oxygen species. Biallelic loss-of-function variants cause chronic granulomatous disease with recurrent bacterial and fungal infections.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in NCF1 have source records linked to Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2. Association strength is not clinical gene validity.
NCF4: Neutrophil cytosol factor 4
It helps organize and regulate phagocyte NADPH oxidase complexes and contributes to reactive-oxygen-species generation in innate immune cells. Biallelic pathogenic variants can cause a milder chronic-granulomatous-disease-like immunodeficiency with recurrent infection and inflammation.
1 ClinVar pathogenic / likely pathogenic and 99 uncertain variants in NCF4 have source records linked to Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| NCF1 R42Q | 42 | PX | Pathogenic / likely pathogenic (★★) |
| NCF4 R105Q | 105 | PX | Pathogenic / likely pathogenic (★★) |
| NCF2 A202V | 202 | Pathogenic / likely pathogenic (★★) | |
| NCF2 Y394D | 394 | PB1 | Pathogenic / likely pathogenic (★★) |
| NCF2 Q285H | 285 | SH3 1 | Pathogenic / likely pathogenic (★★) |
| NCF2 M1T | 1 | Pathogenic / likely pathogenic (★) | |
| NCF1 G192S | 192 | SH3 1 | Pathogenic / likely pathogenic |
| NCF2 D160V | 160 | Pathogenic / likely pathogenic | |
| NCF2 K161E | 161 | Pathogenic / likely pathogenic |
Which prediction tools work for Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 96 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 95 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 87 out of 100
- ESM1b (LLR): 87 out of 100
- PolyPhen-2: 81 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 77 out of 100
Diseases related to Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2
- Chronic granulomatous disease, also linked to NCF1, NCF2 and NCF4
- Systemic lupus erythematosus, also linked to NCF2
Frequently asked questions
Which genes have records linked to Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2?
This view contains 3 analyzed proteins: NCF2, NCF1, NCF4. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 9 pathogenic or likely pathogenic variants, 224 variants of uncertain significance and 16 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 275 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center